Skip to content

Arrowhead Research ARWR WI — Deferred Rent Credit

Discontinued — last reported Q4 '19

Similar metrics at other companies

W.P. Carey Inc. logo
WPCAmortization Of Rent Related Intangibles And Deferred Rental Revenue
-$4.76M-473%
Halozyme Therapeutics logo
HALODeferred Rent Payments
-$214K+15.4%
The Ensign Group logo
ENSGDeferred Rent And Other Long-Term Liabilities
$86.28M+30.7%
Omega Healthcare Investors logo
OHIStraight Line Rent And Other Write Offs
$2.38M-76.2%
PEA
PEAKLifescience — Rent Deferred During The Period
PEA
PEAKMedical office — Deferred rent outstanding

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:DeferredRentCredit.

The official record: Arrowhead Research’s 10-K, filed November 25, 2019, on SEC EDGAR. View the filing →

Questions, answered.

What does WI — deferred rent credit mean?
The accounting balance representing the difference between cash rent paid and the straight-line rent expense recognized for properties in this region.
How do you interpret WI — deferred rent credit?
An increase indicates that the company is currently paying less cash than the recognized expense, which may reverse in future periods.
How does WI — deferred rent credit compare across companies?
Standard accounting metric for companies with significant operating leases, comparable to deferred rent liabilities at other life sciences companies.